Gene and cell therapy firm Oxford Biomedica is to invest £4 million to build digital and robotics capabilities that will help manufacture the next generation of cutting edge therapies.
The UK’s government is urging businesses to apply for a share of up to £1.5 million to support real-world testing of medical devices and digital technology that could make the NHS more effi
Health data firm Litmus Health has been awarded a contract with the National Cancer Institute of the US National Institutes of Health, to use “real-world” digital data to improve drug devel
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.